|
시장보고서
상품코드
2067920
의료용 패시브 콜드체인 포장 시장 규모, 점유율, 동향 분석 : 제품별, 온도 요건별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)Healthcare Passive Cold Chain Packaging Market Size, Share & Trends Analysis Report By Product, By Temperature Requirement, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
의료용 패시브 콜드체인 포장 시장 개요
세계의 의료용 패시브 콜드체인 포장 시장 규모는 2025년에 77억 달러로 추계되며, 2033년까지 188억 달러에 달할 것으로 예측됩니다.
2026-2033년 연평균 성장률(CAGR) 11.9%로 성장할 것으로 전망됩니다. 백신, 바이오의약품, 특수 의약품 등 온도에 민감한 의약품에 대한 수요가 증가하면서, 이것이 시장의 주요 원동력이 되고 있습니다.
또한 전 세계 의약품 유통 네트워크의 확대와 운송 중 제품의 무결성을 유지하기 위한 규제 요건의 강화 역시 시장 성장을 더욱 가속화하고 있습니다. 단일클론 항체, 세포·유전자 치료제, 특수 주사제 등의 제품은 보관 및 운송 전 과정에 걸쳐 일반적으로 2-8℃ 범위내 또는 냉동 상태에서 엄격한 온도 관리가 필요합니다. 온도 편차가 발생하면 제품의 효능이나 안전성이 저하될 우려가 있으므로, 단열 운송 용기, 상변화 물질, 단열 라이너 등 신뢰성이 높은 수동형 포장 솔루션이 필수적입니다. 이러한 고부가가치 치료제에 대한 전 세계적인 수요 증가와 더불어 대규모 예방접종 프로그램의 시행까지 더해지면서, 그 도입은 계속해서 가속화되고 있습니다.
세계 의약품 공급망의 복잡화와 비용 효율적인 물류에 대한 수요가 맞물리면서 시장 성장을 더욱 촉진하고 있습니다. 수동형 콜드체인 포장은 운송 비용 절감, 능동형 냉장 시스템에 대한 의존도 감소, 취급 및 유통 과정에서의 유연성 향상 등 운영상 이점을 제공합니다. 이는 인프라의 제약이나 불안정한 전력 공급이 능동형 콜드체인 시스템의 운영에 어려움을 초래하고 있는 신흥 시장에서 특히 중요한 의미를 지닙니다. 또한 환자에게 직접 배송하는 모델의 부상과 분산형 임상시험의 증가로 인해 휴대성이 뛰어나고 신뢰성이 높은 온도 관리 포장 솔루션에 대한 수요가 더욱 높아지고 있습니다.
규제 준수 요건 또한 시장 성장에 큰 영향을 미치고 있습니다. 미국 식품의약국(FDA) 및 유럽의약품청(EMA) 등 보건 당국은 온도 관리가 필요한 의약품 물류에 관한 엄격한 지침을 마련하고 있으며, 검증된 포장 솔루션과 지속적인 모니터링을 의무화하고 있습니다. 이에 따라 제약 회사와 물류 사업자들은 규정 준수를 확보하고 제품 리스크를 완화할 수 있는 고성능 패시브 포장 시스템에 대한 투자를 추진하고 있습니다. 동시에, 지속가능성에 대한 고려도 점점 더 중요해지고 있으며, 혁신과 장기적인 시장 확대를 지원하는 재사용 및 재활용이 가능한 포장 형태에 대한 관심이 높아지고 있습니다.
자주 묻는 질문
목차
제1장 분석 방법·범위
제2장 개요
제3장 의료용 패시브 콜드체인 포장 시장 : 변동 요인·동향·범위
제4장 의료용 패시브 콜드체인 포장 시장 : 제품별 추정·동향 분석
제5장 의료용 패시브 콜드체인 포장 시장 : 온도 요건별 추정·동향 분석
제6장 의료용 패시브 콜드체인 포장 시장 : 최종 용도별 추정·동향 분석
제7장 의료용 패시브 콜드체인 포장 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSA 26.07.01Healthcare Passive Cold Chain Packaging Market Summary
The global healthcare passive cold chain packaging market size was estimated at USD 7.7 billion in 2025 and is projected to reach USD 18.8 billion by 2033, growing at a CAGR of 11.9% from 2026 to 2033. Rising demand for temperature-sensitive pharmaceuticals, including vaccines, biologics, and specialty drugs, is significantly driving the market.
Besides, the expansion of global pharmaceutical distribution networks and stricter regulatory requirements for maintaining product integrity during transit are further accelerating market growth. Products such as monoclonal antibodies, cell and gene therapies, and specialty injectables require strict temperature control, typically within 2 to 8 degrees Celsius or frozen conditions throughout storage and transportation. Any temperature excursion can compromise product efficacy and safety, making reliable passive packaging solutions such as insulated shippers, phase change materials, and thermal liners essential. The increasing global demand for these high-value therapeutics, along with large-scale immunization programs, continues to accelerate adoption.
An increasing complexity of global pharmaceutical supply chains, combined with the need for cost-efficient logistics, is also boosting the market growth. Passive cold chain packaging provides operational advantages, including lower transportation costs, reduced reliance on active refrigeration systems, and improved flexibility in handling and distribution. This is particularly relevant in emerging markets where infrastructure limitations and inconsistent power supply create challenges for active cold chain systems. In addition, the rise of direct-to-patient delivery models and decentralized clinical trials is further strengthening demand for portable and reliable temperature-controlled packaging solutions.
Regulatory compliance requirements are also significantly influencing market growth. Health authorities such as the US Food and Drug Administration and the European Medicines Agency have established stringent guidelines for temperature-controlled pharmaceutical logistics, requiring validated packaging solutions and continuous monitoring. This has driven pharmaceutical companies and logistics providers to invest in high-performance passive packaging systems that ensure compliance and mitigate product risk. At the same time, sustainability considerations are becoming increasingly important, with a growing focus on reusable and recyclable packaging formats that support innovation and long-term market expansion.
Global Healthcare Passive Cold Chain Packaging Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare passive cold chain packaging market report on the basis of product, temperature requirement, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Insulated Containers
- Insulated Pallet Shippers
- Gel Packs, Dry Ice Systems, PCM
- Others
- Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
- Refrigerated / Chilled (2°C to 8°C)
- Frozen (-20 °C to +-5 °C)
- Cool / Controlled Chilled (8 °C to 15 °C)
- Controlled Room Temperature (CRT)
- Deep Frozen (-40 °C to -60 °C)
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biopharmaceutical Companies
- Hospitals & Healthcare Providers
- Diagnostic & Pathology Laboratories
- Research Institutes & Academic Laboratories
- Clinical Research Organizations (CROs)
- Blood Banks & Plasma Collection Centers
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Types & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Insights
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Healthcare Passive Cold Chain Packaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Raw Material Trends
- 3.3.2. Technology/Manufacturing Trends
- 3.3.3. Sales Channel Analysis
- 3.3.4. Profit Margin Analysis
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Industry Challenges
- 3.5.4. Industry Opportunities
- 3.6. Porter's Five Forces Analysis
- 3.6.1. Supplier Power
- 3.6.2. Buyer Power
- 3.6.3. Substitution Threat
- 3.6.4. Threat from New Entrants
- 3.6.5. Competitive Rivalry
- 3.7. PESTEL Analysis
- 3.7.1. Political Landscape
- 3.7.2. Economic Landscape
- 3.7.3. Social Landscape
- 3.7.4. Technological Landscape
- 3.7.5. Environmental Landscape
- 3.7.6. Legal Landscape
Chapter 4. Healthcare Passive Cold Chain Packaging Market: Product Estimates & Trend Analysis
- 4.1. Definition & Scope
- 4.2. Key Takeaways
- 4.3. Product Movement Analysis & Market Share, 2025 & 2033
- 4.3.1. Insulated Containers
- 4.3.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.2. Insulated Pallet Shippers
- 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.3. Gel Packs, Dry Ice Systems, PCM
- 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.4. Others
- 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.1. Insulated Containers
Chapter 5. Healthcare Passive Cold Chain Packaging Market: Temperature Requirement Estimates & Trend Analysis
- 5.1. Definition & Scope
- 5.2. Key Takeaways
- 5.3. Temperature Requirement Movement & Market Share Analysis, 2025 & 2033
- 5.3.1. Refrigerated / Chilled (2°C to 8°C)
- 5.3.1.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Frozen (-20 °C to +-5 °C)
- 5.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.3. Cool / Controlled Chilled (8 °C to 15 °C)
- 5.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.4. Controlled Room Temperature (CRT)
- 5.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.5. Deep Frozen (-40 °C to -60 °C)
- 5.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.1. Refrigerated / Chilled (2°C to 8°C)
Chapter 6. Healthcare Passive Cold Chain Packaging Market: End Use Estimates & Trend Analysis
- 6.1. Definition & Scope
- 6.2. Key Takeaways
- 6.3. End Use Movement Analysis & Market Share, 2025 & 2033
- 6.3.1. Pharmaceutical & Biopharmaceutical Companies
- 6.3.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Hospitals & Healthcare Providers
- 6.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Diagnostic & Pathology Laboratories
- 6.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.4. Research Institutes & Academic Laboratories
- 6.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.5. Clinical Research Organizations (CROs)
- 6.3.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.6. Blood Banks & Plasma Collection Centers
- 6.3.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.7. Others
- 6.3.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.1. Pharmaceutical & Biopharmaceutical Companies
Chapter 7. Healthcare Passive Cold Chain Packaging Market: Regional Estimates & Trend Analysis
- 7.1. Key Takeaways
- 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.3.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.3.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.3.5. U.S.
- 7.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.3.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.3.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.3.6. Canada
- 7.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.3.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.3.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.3.7. Mexico
- 7.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.7.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.3.7.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.3.7.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4.5. Germany
- 7.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4.6. UK
- 7.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4.7. France
- 7.4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.7.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.7.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4.8. Italy
- 7.4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.8.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.8.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.4.9. Spain
- 7.4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.4.9.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.4.9.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5.5. China
- 7.5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5.6. India
- 7.5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5.7. Japan
- 7.5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.7.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.7.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5.8. South Korea
- 7.5.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.8.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.8.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.5.9. Australia
- 7.5.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.5.9.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.5.9.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.6.5. Brazil
- 7.6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.6.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.6.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.6.6. Argentina
- 7.6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.6.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.6.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.7. Middle East & Africa
- 7.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.7.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.7.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.7.5. Saudi Arabia
- 7.7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.7.5.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.7.5.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.7.6. South Africa
- 7.7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.6.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.7.6.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.7.6.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
- 7.7.7. UAE
- 7.7.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.7.2. Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
- 7.7.7.3. Market Estimates and Forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
- 7.7.7.4. Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Vendor Landscape
- 8.2.1. Company Categorization
- 8.2.2. Raw Material Suppliers & Channel Partners
- 8.2.3. List of Potential Customers/End-users
- 8.3. Competitive Dynamics
- 8.3.1. Company Market Positioning Analysis
- 8.3.2. Strategy Mapping
- 8.3.3. Heat Map Analysis
- 8.4. Company Profiles/Listing
- 8.4.1. Participant's Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.3.1. Sonoco ThermoSafe
- 8.4.3.2. Cold Chain Technologies
- 8.4.3.3. Peli BioThermal LLC
- 8.4.3.4. Cryopak
- 8.4.3.5. CSafe
- 8.4.3.6. DGP Intelsius LLC
- 8.4.3.7. TemperPack
- 8.4.3.8. Taylor Corporation
- 8.4.3.9. Ernest Packaging Solutions
- 8.4.3.10. TEMPACK
- 8.4.3.11. Insulated Products Corporation
